Los Angeles, CA77 Active Studies

Essential Tremor Clinical Trials in Los Angeles, CA

Find 77 actively recruiting essential tremor clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

77
Active Trials
60
Sponsors
52,773
Enrolling

Recruiting Essential Tremor Studies in Los Angeles

About Essential Tremor Clinical Trials in Los Angeles

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 77 essential tremor clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 52,773 participants. Research is being sponsored by Brigham and Women's Hospital, University of Colorado, Denver, University of Michigan and 57 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Los Angeles — FAQ

Are there essential tremor clinical trials in Los Angeles?

Yes, there are 77 essential tremor clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 77 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 16, 2026 from ClinicalTrials.gov